Cargando…

NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS

BACKGROUND AND PURPOSE: Radiation necrosis occurs from 6 months to several years following stereotactic irradiation (STI) for brain metastases when tumor recurrences are also most likely. Conventional MR imaging does not provide sufficient information to differentiate between radiation necrosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsuya, Koichi, Deguchi, Shoichi, Ito, Shohei, Asakura, Koiku, Nakashima, Kazuaki, Oishi, Takuma, Sugino, Takashi, Hayashi, Nakamasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354227/
http://dx.doi.org/10.1093/noajnl/vdac078.074
_version_ 1784763019487608832
author Mitsuya, Koichi
Deguchi, Shoichi
Ito, Shohei
Asakura, Koiku
Nakashima, Kazuaki
Oishi, Takuma
Sugino, Takashi
Hayashi, Nakamasa
author_facet Mitsuya, Koichi
Deguchi, Shoichi
Ito, Shohei
Asakura, Koiku
Nakashima, Kazuaki
Oishi, Takuma
Sugino, Takashi
Hayashi, Nakamasa
author_sort Mitsuya, Koichi
collection PubMed
description BACKGROUND AND PURPOSE: Radiation necrosis occurs from 6 months to several years following stereotactic irradiation (STI) for brain metastases when tumor recurrences are also most likely. Conventional MR imaging does not provide sufficient information to differentiate between radiation necrosis and tumor recurrence. Methionine-PET, FDG-PET and MR spectroscopy sometimes lead to false positive findings. We applied 320-row area detector CT perfusion imaging for the differentiation because it shows vascularity of lesions in the whole brain. MR T1/T2 match sign also evaluate because it is convenient diagnostic method. METHOD: Between October 2006 and September 2021, 48 lesions enlarged in 46 patients 3 to 122 months (median: 11 months) after STI. Differential diagnosis was performed with CT perfusion imaging and MR T1/T2 match sign. To calculate the regional cerebral blood volume (rCBV), the regions of interest (ROIs) were located in the enhanced areas. The lesions progressively increased in size or became symptomatic were resected and diagnosed by pathological examination. RESULTS: Mean age was 63 years, and 60% were male. Primary were lung 31, breast 9, kidney 3, colon 2, melanoma 2, and uterus 1. Mean time to progression from STI was 11 months (range; 3-122). Pathological diagnosis revealed 38 lesions (79%) had tumor recurrence, and 10 (21%) had radiation necrosis. A cut off value rCBV of greater than 3.0 analyzed by ROC curve provided the best sensitivity and specificity for identifying recurrent metastatic tumors, at 89% and 100%, respectively. T1/T2 match sign was provided sensitivity and specificity for identifying recurrent tumors, at 84% and 90%, respectively. To estimate intralesional pathological heterogeneity, contradistinction of CBV map and T1/T2 match sign is useful for the choice of intraoperative maneuver. CONCLUSION: Perfusion CT imaging and T1/T2 match sign demonstrated reliable methods for differentiating tumor recurrence from radiation necrosis after STI.
format Online
Article
Text
id pubmed-9354227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93542272022-08-09 NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS Mitsuya, Koichi Deguchi, Shoichi Ito, Shohei Asakura, Koiku Nakashima, Kazuaki Oishi, Takuma Sugino, Takashi Hayashi, Nakamasa Neurooncol Adv Supplement Abstracts BACKGROUND AND PURPOSE: Radiation necrosis occurs from 6 months to several years following stereotactic irradiation (STI) for brain metastases when tumor recurrences are also most likely. Conventional MR imaging does not provide sufficient information to differentiate between radiation necrosis and tumor recurrence. Methionine-PET, FDG-PET and MR spectroscopy sometimes lead to false positive findings. We applied 320-row area detector CT perfusion imaging for the differentiation because it shows vascularity of lesions in the whole brain. MR T1/T2 match sign also evaluate because it is convenient diagnostic method. METHOD: Between October 2006 and September 2021, 48 lesions enlarged in 46 patients 3 to 122 months (median: 11 months) after STI. Differential diagnosis was performed with CT perfusion imaging and MR T1/T2 match sign. To calculate the regional cerebral blood volume (rCBV), the regions of interest (ROIs) were located in the enhanced areas. The lesions progressively increased in size or became symptomatic were resected and diagnosed by pathological examination. RESULTS: Mean age was 63 years, and 60% were male. Primary were lung 31, breast 9, kidney 3, colon 2, melanoma 2, and uterus 1. Mean time to progression from STI was 11 months (range; 3-122). Pathological diagnosis revealed 38 lesions (79%) had tumor recurrence, and 10 (21%) had radiation necrosis. A cut off value rCBV of greater than 3.0 analyzed by ROC curve provided the best sensitivity and specificity for identifying recurrent metastatic tumors, at 89% and 100%, respectively. T1/T2 match sign was provided sensitivity and specificity for identifying recurrent tumors, at 84% and 90%, respectively. To estimate intralesional pathological heterogeneity, contradistinction of CBV map and T1/T2 match sign is useful for the choice of intraoperative maneuver. CONCLUSION: Perfusion CT imaging and T1/T2 match sign demonstrated reliable methods for differentiating tumor recurrence from radiation necrosis after STI. Oxford University Press 2022-08-05 /pmc/articles/PMC9354227/ http://dx.doi.org/10.1093/noajnl/vdac078.074 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Abstracts
Mitsuya, Koichi
Deguchi, Shoichi
Ito, Shohei
Asakura, Koiku
Nakashima, Kazuaki
Oishi, Takuma
Sugino, Takashi
Hayashi, Nakamasa
NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
title NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
title_full NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
title_fullStr NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
title_full_unstemmed NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
title_short NEIM-07 DIFFERENTIAL DIAGNOSIS OF TUMOR RECURRENCE AND RADIATION NECROSIS AFTER STEREOTACTIC RADIOTHERAPY FOR BRAIN METASTASES WITH 320-ROW ADCT PERFUSION IMAGE AND T1/T2 MATCH: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
title_sort neim-07 differential diagnosis of tumor recurrence and radiation necrosis after stereotactic radiotherapy for brain metastases with 320-row adct perfusion image and t1/t2 match: radiological and pathological analysis
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354227/
http://dx.doi.org/10.1093/noajnl/vdac078.074
work_keys_str_mv AT mitsuyakoichi neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT deguchishoichi neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT itoshohei neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT asakurakoiku neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT nakashimakazuaki neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT oishitakuma neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT suginotakashi neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis
AT hayashinakamasa neim07differentialdiagnosisoftumorrecurrenceandradiationnecrosisafterstereotacticradiotherapyforbrainmetastaseswith320rowadctperfusionimageandt1t2matchradiologicalandpathologicalanalysis